Optomed Oyj reported earnings results for the first quarter ended March 31, 2023. For the first quarter, the company reported sales was EUR 3.48 million compared to EUR 3.21 million a year ago. Net loss was EUR 1.16 million compared to EUR 1.37 million a year ago.

Basic loss per share from continuing operations was EUR 0.08 compared to EUR 0.1 a year ago.